MyD88-dependent pathway accelerates the liver damage of Concanavalin A-induced hepatitis

Biochemical and Biophysical Research Communications

Volumn 399, Issue 4, 2010, Pages 744-749

  Ojiro, Keisuke ^a   Ebinuma, Hirotoshi ^a   Nakamoto, Nobuhiro ^a   Wakabayashi, Kanji ^a   Mikami, Yohei ^a   Ono, Yuichi ^a   Po Sung, Chu ^a   Usui, Shingo ^a   Umeda, Rumiko ^a   Takaishi, Hiromasa ^a   Yamagishi, Yoshiyuki ^a   Saito, Hidetsugu ^a   Kanai, Takanori ^a   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Concanavalin A; Hepatitis; Macrophage; MyD88; Toll like receptors

Indexed keywords

AMINOTRANSFERASE; B7 ANTIGEN; CD11B ANTIGEN; CD86 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; MYD88 PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; DISEASE SEVERITY; FLOW CYTOMETRY; HISTOPATHOLOGY; LIVER INJURY; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; LIVER; MACROPHAGE ACTIVATION; METABOLISM; PATHOLOGY;

ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; CONCANAVALIN A; DISEASE MODELS, ANIMAL; HEPATITIS, AUTOIMMUNE; LIVER; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS;

EID: 77956268723     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.012     Document Type: Article

References (18)

1. Crispe I.N. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 2002, 3:51-62.
2. Crispe I.N. The liver as a lymphoid organ. Annu. Rev. Immunol. 2009, 27:147-163.
3. Seki E., Brenner D.A. Toll-like receptors, adaptive molecules in liver disease: update. Hepatology 2008, 48:322-335.
4. Krawitt E.L. Autoimmune hepatitis, New Engl. J. Med. 2006, 24:783-801.
5. Akira S., Uematsu S.S., Takeuchi O. Pathogen recognition, innate immunity. Cell 2006, 24:783-801.
6. Dong Z., Wei H., Sun R., Tian Z. The roles of innate cells in liver injury, regeneration. Cell Mol.Immunol. 2007, 4:241-252.
7. Tiegs G., Hentschel J., Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 1992, 90:196-203.
8. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999, 11:115-122.
9. Nemoto Y., Kanai T., Kameyama K., Shinohara T., Sakamoto N., Totsuka T., Okamoto R., Tsuchiya K., Nakamura T., Sudo T., Matsumoto S., Watanabe M. Long-lived colitogenic CD4+ memory T cells residing outside the intestine participate in the perpetuation of chronic colitis. J. Immunol. 2009, 183:5059-5068.
10. + T cells in chronic colitis. J. Immunol. 2008, 180:5291-5299.
11. Küsters S., Tiegs G., Alexopoulou L., Pasparakis M., Douni E., Künstle G., Bluethmann H., Wendel A., Pfizenmaier K., Kollias G., Grell M. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol. 1997, 27:2870-2875.
12. Takeda K., Hayakawa K.Y., Van Kaer L., Matsuda H., Yagita H., Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis., Proc. Natl. Acad. Sci. USA 2000, 97:5498-5503.
13. Halder R.C., Seki S., Weerasinghe A., Kawamura T., Watanabe H., Abo T. Characterization of NK cells and extrathymic T cells generated in the liver of irradiated mice with a liver shield. Clin. Exp. Immunol. 1998, 114:434-447.
14. Tu Z., Bozorgzadeh A., Crispe I.N., Orloff M.S. The activation state of human intrahepatic lymphocytes. Clin. Exp. Immunol. 2007, 149:186-193.
15. + T cells and their IFN-gamma production in the generalized Shwartzman reaction. J. Immunol. 1998, 160:3522-3527.
16. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and Il-18-mediated function. Immunity 1998, 9:143-150.
17. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., Janeway C.A. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Moll. Cell 1998, 2:253-258.
18. XiaoP X., Zhao D., Rodriguez-Pinto D., Qi O., Henegariu L., Alexopoulou R.A., FlavellF S., Wong L.Wen. Inflammatory regulation by TLR3 in acute hepatitis. J. Immunol. 2009, 183:3712-3719.